Jazz Pharmaceuticals plc (JAZZ) › Capital ExpendituresJazz Pharmaceuticals plc (JAZZ) — Capital ExpendituresAnnual figures by period end, from SEC filings.2018-12-31: $20.37M2019-12-31: $40.13M2020-12-31: $15.00M2021-12-31: $27.64M2022-12-31: $29.05M2023-12-31: $23.96M2024-12-31: $38.07M2025-12-31: $58.75M$58.75M2018-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$58.75M+54.3%2026-02-24From 2025-01-012024-12-31$38.07M+58.9%2026-02-24From 2024-01-012023-12-31$23.96M-17.5%2026-02-24From 2023-01-012022-12-31$29.05M+5.1%2025-02-26From 2022-01-012021-12-31$27.64M+84.2%2024-02-28From 2021-01-012020-12-31$15.00M-62.6%2023-03-01From 2020-01-012019-12-31$40.13M+97.0%2022-03-01From 2019-01-012018-12-31$20.37M—2021-02-23From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)